✦ LIBER ✦

Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study

✍ Scribed by B. I. ERIKSSON; O. E. DAHL; M. R. LASSEN; D. P. WARD; R. ROTHLEIN; G. DAVIS; A. G. G. TURPIE; FOR THE FIXIT STUDY GROUP

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral, direct Factor Xa inhibition with B

✍ B. I. ERIKSSON; L. BORRIS; O. E. DAHL; S. HAAS; M. V. HUISMAN; A. K. KAKKAR; F. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

Prevention of venous thromboembolism wit

✍ B. I. ERIKSSON; A. G. G. TURPIE; M. R. LASSEN; M. H. PRINS; G. AGNELLI; P. KÄLEB 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

A dose escalation study of YM150, an ora

✍ B. I. ERIKSSON; A. G. G. TURPIE; M. R. LASSEN; M. H. PRINS; G. AGNELLI; P. KÄLEB 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

Dose-escalation study of rivaroxaban (BA

✍ Bengt I. Eriksson; Lars C. Borris; Ola E. Dahl; Sylvia Haas; Menno V. Huisman; A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 302 KB

BAY 59-7939: an oral, direct Factor Xa i

✍ A. G. G. TURPIE; W. D. FISHER; K. A. BAUER; L. M. KWONG; M. W. IRWIN; P. KÄLEBO; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB